Pure Testicular Seminoma Relapsing Late with Somatic Type Malignancy

Background. Somatic type malignancy (STM) occurs in 2% of all germ cell tumours (GCTs). The prognosis is unfavourable and the origin is poorly understood. Pathogenetic hypotheses involve direct transformation of teratoma, origin from totipotent cancer cells, or derivation from yolk sac tumour elemen...

Full description

Saved in:
Bibliographic Details
Main Authors: Klaus-Peter Dieckmann, Petra Anheuser, Ralf Gehrckens, Waldemar Wilczak, Guido Sauter, Doris Höflmayer
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2017/2457023
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567576302977024
author Klaus-Peter Dieckmann
Petra Anheuser
Ralf Gehrckens
Waldemar Wilczak
Guido Sauter
Doris Höflmayer
author_facet Klaus-Peter Dieckmann
Petra Anheuser
Ralf Gehrckens
Waldemar Wilczak
Guido Sauter
Doris Höflmayer
author_sort Klaus-Peter Dieckmann
collection DOAJ
description Background. Somatic type malignancy (STM) occurs in 2% of all germ cell tumours (GCTs). The prognosis is unfavourable and the origin is poorly understood. Pathogenetic hypotheses involve direct transformation of teratoma, origin from totipotent cancer cells, or derivation from yolk sac tumour elements. Case Presentation. A 31-year-old patient was cured from testicular seminoma clinical stage IIc by orchiectomy and cisplatin-based chemotherapy. Nine years later, he experienced a late relapse with a mass sized 5×6 cm located at the former metastatic site. As no remission occurred after chemotherapy with three cycles of cisplatin, ifosfamide and etoposide, the mass was surgically resected. Histologically, the specimen consisted of neurofibroma with areas of malignant peripheral nerve sheath tumour and spots with mature bone formation. FISH analysis disclosed isochromosome 12p in the majority of evaluated cells suggesting somatic type malignancy (STM) of GCT. The patient is well 1 year after surgery. Conclusion. The pathogenesis of this STM remains enigmatic. The origin from GCT was evidenced by documentation of isochromosome 12p. Unrecognized teratomatous elements in the primary and totipotent cancer cells surviving the first chemotherapy could be hypothesized to represent the origin. STM developing from seminoma cells would be another novel hypothesis.
format Article
id doaj-art-34501efd7439452d810ad78707b57cec
institution Kabale University
issn 2090-6706
2090-6714
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Case Reports in Oncological Medicine
spelling doaj-art-34501efd7439452d810ad78707b57cec2025-02-03T01:01:04ZengWileyCase Reports in Oncological Medicine2090-67062090-67142017-01-01201710.1155/2017/24570232457023Pure Testicular Seminoma Relapsing Late with Somatic Type MalignancyKlaus-Peter Dieckmann0Petra Anheuser1Ralf Gehrckens2Waldemar Wilczak3Guido Sauter4Doris Höflmayer5Department of Urology, Albertinen-Krankenhaus Hamburg, Süntelstrasse 11a, 22457 Hamburg, GermanyDepartment of Urology, Albertinen-Krankenhaus Hamburg, Süntelstrasse 11a, 22457 Hamburg, GermanyDepartment of Diagnostic Radiology, Albertinen-Krankenhaus Hamburg, Süntelstrasse 11a, 22457 Hamburg, GermanyInstitute of Pathology, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, GermanyInstitute of Pathology, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, GermanyInstitute of Pathology, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, GermanyBackground. Somatic type malignancy (STM) occurs in 2% of all germ cell tumours (GCTs). The prognosis is unfavourable and the origin is poorly understood. Pathogenetic hypotheses involve direct transformation of teratoma, origin from totipotent cancer cells, or derivation from yolk sac tumour elements. Case Presentation. A 31-year-old patient was cured from testicular seminoma clinical stage IIc by orchiectomy and cisplatin-based chemotherapy. Nine years later, he experienced a late relapse with a mass sized 5×6 cm located at the former metastatic site. As no remission occurred after chemotherapy with three cycles of cisplatin, ifosfamide and etoposide, the mass was surgically resected. Histologically, the specimen consisted of neurofibroma with areas of malignant peripheral nerve sheath tumour and spots with mature bone formation. FISH analysis disclosed isochromosome 12p in the majority of evaluated cells suggesting somatic type malignancy (STM) of GCT. The patient is well 1 year after surgery. Conclusion. The pathogenesis of this STM remains enigmatic. The origin from GCT was evidenced by documentation of isochromosome 12p. Unrecognized teratomatous elements in the primary and totipotent cancer cells surviving the first chemotherapy could be hypothesized to represent the origin. STM developing from seminoma cells would be another novel hypothesis.http://dx.doi.org/10.1155/2017/2457023
spellingShingle Klaus-Peter Dieckmann
Petra Anheuser
Ralf Gehrckens
Waldemar Wilczak
Guido Sauter
Doris Höflmayer
Pure Testicular Seminoma Relapsing Late with Somatic Type Malignancy
Case Reports in Oncological Medicine
title Pure Testicular Seminoma Relapsing Late with Somatic Type Malignancy
title_full Pure Testicular Seminoma Relapsing Late with Somatic Type Malignancy
title_fullStr Pure Testicular Seminoma Relapsing Late with Somatic Type Malignancy
title_full_unstemmed Pure Testicular Seminoma Relapsing Late with Somatic Type Malignancy
title_short Pure Testicular Seminoma Relapsing Late with Somatic Type Malignancy
title_sort pure testicular seminoma relapsing late with somatic type malignancy
url http://dx.doi.org/10.1155/2017/2457023
work_keys_str_mv AT klauspeterdieckmann puretesticularseminomarelapsinglatewithsomatictypemalignancy
AT petraanheuser puretesticularseminomarelapsinglatewithsomatictypemalignancy
AT ralfgehrckens puretesticularseminomarelapsinglatewithsomatictypemalignancy
AT waldemarwilczak puretesticularseminomarelapsinglatewithsomatictypemalignancy
AT guidosauter puretesticularseminomarelapsinglatewithsomatictypemalignancy
AT dorishoflmayer puretesticularseminomarelapsinglatewithsomatictypemalignancy